LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 96 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2017. The put-call ratio across all filers is 1.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | – | 200 | -71.4% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 700 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $6,000 | -90.6% | 700 | -68.2% | 0.00% | -80.0% |
| Q2 2018 | $64,000 | +300.0% | 2,200 | -48.4% | 0.01% | +150.0% |
| Q1 2018 | $16,000 | -97.4% | 4,260 | -94.4% | 0.00% | -92.3% |
| Q4 2017 | $619,000 | +6.4% | 75,929 | -13.6% | 0.03% | +18.2% |
| Q3 2017 | $582,000 | +31.7% | 87,913 | +23.8% | 0.02% | +29.4% |
| Q2 2017 | $442,000 | +21.8% | 71,000 | -11.1% | 0.02% | +6.2% |
| Q1 2017 | $363,000 | +142.0% | 79,880 | +109.4% | 0.02% | +166.7% |
| Q4 2016 | $150,000 | -33.9% | 38,148 | +43.9% | 0.01% | -40.0% |
| Q3 2016 | $227,000 | +54.4% | 26,516 | -27.0% | 0.01% | +42.9% |
| Q2 2016 | $147,000 | +297.3% | 36,300 | +200.0% | 0.01% | +133.3% |
| Q1 2016 | $37,000 | -9.8% | 12,100 | +646.9% | 0.00% | +50.0% |
| Q4 2015 | $41,000 | – | 1,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |